Prevalence of musculoskeletal conditions and associated factors with joint pain in individuals with Chikungunya in Amapá, Brazil: a cross-sectional study
DOI:
https://doi.org/10.33233/fb.v24i6.5515Keywords:
Chikungunya fever, epidemiology, joints, musculoskeletal painAbstract
Introduction: Chikungunya fever is an infectious disease caused by the Chikungunya virus (CHIKV), with joint pain being the most common symptom in these cases. The disease often presents with musculoskeletal dysfunctions (MS) that can sometimes be debilitating. In Brazil, since 2014, cases have been identified, with high infection rates. In the state of Amapá, in the far north of the country, there have been no studies that profile the infected population and their clinical and musculoskeletal manifestations post-Chikungunya infection. Objective: To identify the prevalence of musculoskeletal manifestations and factors associated with joint pain in individuals with Chikungunya fever in the state of Amapá, Brazil. Methods: A cross-sectional and retrospective study analyzed data from the SINAN NET system of the Ministry of Health (MH) from 869 individuals infected with CHIKV. Sociodemographic and clinical data from diagnosed individuals were used. Data correctly filled out in accordance with the MH identification and notification form were included in the study, while incompletely filled forms were excluded. Descriptive and inferential analyses were performed, with a significance level of 5% (p < 0.05) and a 95% confidence interval (CI). Results: Muscle pain (75.4%) and back pain (57.3%) were the most prevalent musculoskeletal conditions. The results indicate a positive and direct association between joint pain and arthritis (OR=2.56/CI = 1.90–3.46); fever (OR: 2.42; CI: 1.27–4.60); back pain (OR: 4.34; CI: 3.26–5.80); myalgia (OR: 4.89; CI: 3.43 – 6.98); headache (OR: 3.69; CI: 2.45–5.55); and rash (OR: 1.89; CI: 1.44–2.48). Conclusion: In the analyzed sample, it was observed that muscle pain and back pain were even more prevalent than joint pain. The presence of these two musculoskeletal complaints is still strongly associated with complaints of joint pain in these individuals. These findings may alert healthcare professionals to a more rigorous monitoring of individuals with multiple musculoskeletal conditions after CHIK, with the aim of preventing the possible chronicity of joint complaints.
References
Marques CDL, Duarte ALBP, Ranzolin A, Dantas AT, Cavalcanti NG, Gonçalves RSG, et al. Recomendações da Sociedade Brasileira de Reumatologia para diagnóstico e tratamento da febre chikungunya. Parte 1 – Diagnóstico e situações especiais. Rev Bras Reumatol. 2017;57(S2):421–37. doi: 10.1016/j.rbr.2017.05.005
Sales GMPG, Barbosa ICP, Neta LMSC, Melo PL, Azevedo Leitão R, Albuquerque Melo HM. Treatment of chikungunya chronic arthritis: A systematic review. Rev Assoc Med Bras. 2018;64(1):63–70. doi: 10.1590/1806-9282.64.01.63
Castro APCR, Lima RA, Nascimento JS. Chikungunya: vision of the pain clinician. Rev Dor [Internet]. 2016;17(4):299–302. doi/10.5935/1806-0013.20160093
Miner JJ, Yeang HXA, Fox JM, Taffner S, Malkova ON, Oh ST, et al. Brief report: Chikungunya viral arthritis in the United States: A mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 2015;67(5):1214–20. doi: 10.1002/art.39027
Goupil BA, Mores CN. A Review of Chikungunya Virus-induced arthralgia: clinical manifestations, therapeutics, and pathogenesis. Open Rheumatol J [Internet]. 2016;10:129–40. doi: 10.2174/1874312901610010129
McCarthy MK, Morrison TE. Chronic chikungunya virus musculoskeletal disease: What are the underlying mechanisms? Future Microbiol. 2016;11(3):331–4. doi: 10.2217/fmb.15.147
Cardoso Pereira AB, Fernandes De Albuquerque LC, Medeiros Souza RC, Freire De Carvalho J, Muniz Caldas CA. Musculoskeletal Manifestations Observed in Patients Diagnosed With Chikungunya Virus in 2 Municipalities of the Brazilian Amazon Region. J Clin Rheumatol. 2020;26:S195–8. doi: 10.1097/rhu.0000000000001366
Nunes MRT, Faria NR, Vasconcelos JM, Golding N, Kraemer MUG, Oliveira LF, et al. Emergence and potential for spread of Chikungunya virus in Brazil. BMC Med [Internet]. 2015;13(1). doi: 10.1186/s12916-015-0348-x
Azevedo RSS, Oliveira CS, Vasconcelos PFC. Chikungunya risk for Brazil. Rev Saude Publica. 2015;49. doi: 10.1590/s0034-8910.2015049006219
Malta M, Cardoso LO, Bastos FI, Magnanini MMF, Silva CMFP. Iniciativa STROBE: subsídios para a comunicação de estudos observacionais. Rev Saude Publica. 2010;44(3):559–65. doi: 10.1590/S0034-89102010000300021
Hayd RLN, Moreno MR, Naveca F, Amdur R, Suchowiecki K, Watson H, et al. Persistent Chikungunya arthritis in Roraima, Brazil. Clin Rheumatol. 2020;39(9):2781–7. doi: 10.1007/s10067-020-05011-9
Honório NA, Câmara DCP, Calvet GA, Brasil P. Chikungunya: an arbovirus infection in the process of establishment and expansion in Brazil. Cad Saude Publica. 2015;31(5):906–8. doi: 10.1590/0102-311xpe020515
Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K. Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J. 2013;89(1054):440–7. doi: 10.1136/postgradmedj-2012-131477
Bouquillard E, Fianu A, Bangil M, Charlette N, Ribéra A, Michault A, et al. Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study). Jt Bone Spine. 2018;85(2):207–10. doi: 10.1016/j.jbspin.2017.01.014
Delia R. Lineamientos técnicos para la prevención y el tratamiento de la fiebre chikunguña. 2015. [citado 2023 Mar 13]. Disponible en: http://www.redalyc.org/articulo.oa?id=457744935019
Lázari CDS, Ramundo MS, Ten-Caten F, Bressan CS, de Filippis AMB, Manuli ER, et al. Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort. PLoS Negl Trop Dis. 2023;17(1):1–17. doi: 10.1371/journal.pntd.0011037
Pinto JR, da Silva Junior GB, Mota RMS, Martins P, Santos AKT, de Moura DCN, et al. Clinical profile and factors associated with hospitalizatioduring a Chikungunya epidemic in Ceará, Brazil. Rev Soc Bras Med Trop. 2019;52(August):0–2. doi: 10.1590/0037-8682-0167-2019
Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest. 2010;120(3):894–906. doi: 10.1172/jci40104
Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3(12):1895–906. doi: 10.1371/journal.ppat.0030201
Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, et al. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007;3(6):804–17. doi: 10.1371/journal.ppat.0030089
Couderc T, Lecuit M. Chikungunya virus pathogenesis: From bedside to bench. Antiviral Res. 2015;121:120–31. doi: 10.1016/j.antiviral.2015.07.002
Published
Issue
Section
License
Copyright (c) 2023 Cecília Emily Costa dos Santos, Daniely Prado Barros, Alessandro Pena Matos, Maycon Sousa Pegorari, Cleuton Braga Landre, Natália Camargo Rodrigues Iosimuta, Areolino Pena Matos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are authorized for non-exclusive distribution of the version of the work published in this journal (eg, publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
